ArticleCureus2026
Association of Coronary Microvascular Dysfunction With Cerebrovascular Risk and Cognitive Decline in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus is associated with microvascular complications that may contribute to both cardiovascular and neurological morbidity.
objectiveTo evaluate the association of coronary microvascular dysfunction with stroke risk, cognitive decline, and selected hematologic/metabolic biomarkers in patients with type 2 diabetes mellitus without major vessel occlusion.
methodsThis analytical cross-sectional study was conducted at the Department of Cardiology, Jinnah International Hospital, Abbottabad, Pakistan, from May 2025 to November 2025. A total of 255 patients with type 2 diabetes mellitus were enrolled using non-probability consecutive sampling. Coronary microvascular dysfunction was assessed through clinical evaluation and available cardiovascular investigations in patients without significant epicardial coronary artery obstruction.
resultsThe mean age of the participants was 54.7 ± 10.9 years, and 146 (57.3%) were male. Coronary microvascular dysfunction was identified in 112 (43.9%) patients. Cognitive decline was significantly more frequent among patients with coronary microvascular dysfunction than those without it (46.4% vs. 29.4%, p = 0.006). Elevated stroke risk was also higher in patients with coronary microvascular dysfunction (43.8% vs. 23.1%, p = 0.001). Patients with coronary microvascular dysfunction had longer diabetes duration (10.1 ± 4.3 vs. 7.4 ± 3.6 years, p = 0.001), higher glycosylated hemoglobin levels (8.9 ± 1.6% vs. 7.8 ± 1.4%, p = 0.001), higher low-density lipoprotein cholesterol levels (142.1 ± 27.5 vs. 128.4 ± 28.7 mg/dL, p = 0.004), and greater frequencies of hypertension (63.4% vs. 46.9%, p = 0.012) and dyslipidemia (55.4% vs. 41.3%, p = 0.028).
conclusionCoronary microvascular dysfunction was common among patients with type 2 diabetes mellitus and was significantly associated with cognitive decline, elevated stroke risk, and adverse metabolic profiles. Early identification of microvascular dysfunction may improve vascular risk stratification and guide preventive strategies in diabetic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.